Fierce Biotech1 min read
saveCognito phase 3 flops in light-and-sound Alzheimer's trial, but sees ‘signal’ for HOPE
Cognito Therapeutics said its phase 3 HOPE study of Spectris AD, an investigational, non-invasive, at-home Alzheimer's therapy that uses light and sound stimulation to engage brain activity, failed to meet its primary endpoint.
comments(0)
5-min edit window · permanent after that